Page 123 - JSOM Fall 2020
P. 123

evacuation hospital via computed tomography on postopera-  Financial Disclosure
              tive day 3. Oxygen and nasal cannula were available on site,   The authors have no relevant financial relationships to disclose.
              but in a more austere location and over longer time periods,
              this effect would have to be solved through aggressive pul-  References
              monary toilet. This patient presented with a significant lower   1.  Schauer S, April M, Aden J, et al. Impact of continuous ketamine
              extremity fracture, which made mobilization as a treatment   infusion versus alternative regimens on mortality among burn in-
              for atelectasis impossible.                          tensive care unit patients: implications for prolonged field care. J
                                                                   Spec Oper Med. 2019;19(2):77–80.
                                                                 2.  Schwenk E, Viscusi E, Buvanendran A, et al. Consensus guidelines
                                                                   on the use of intravenous ketamine infusions for acute pain man-
              Conclusion                                           agement from the American Society of Regional Anesthesia and
                                                                   Pain Medicine, the American Academy of Pain Medicine, and the
              In an austere setting over approximately 48 hours, a continuous   American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;
              ketamine infusion proved highly effective for analgesia, work-  43(5):456–466.
              load mitigation, and supply utilization in an extubated post-  3.  Oddo M, Crippa I, Mehta S, et al. Optimizing sedation in patients
              surgical patient. Atelectasis, somnolence, and disorientation   with acute brain injury. Crit Care. 2016;20:128.
              were side-effects that may hamper its use over long durations.   4.  KETALAR (ketamine hydrochloride) injection.  FDA.gov. Refer-
              In a setting where oxygen supplementation or other methods of   ence ID: 4089409.
              treatment are not available, atelectasis may be a limiting factor.

              Author Contributions
              A.H. conceived the study concept and wrote the first draft. A.H.,
              L.M., and M.D. coordinated and collected the data, revised the
              manuscript, and read and approved the final manuscript.


























































                                                                                                         Hall  |  121
   118   119   120   121   122   123   124   125   126   127   128